6OI2
Crystal structure of human WDR5 in complex with symmetric dimethyl-L-arginine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 31-ID |
Synchrotron site | APS |
Beamline | 31-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2018-10-24 |
Detector | RAYONIX MX225HE |
Wavelength(s) | 0.97931 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 81.053, 86.285, 40.865 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 59.080 - 1.680 |
R-factor | 0.18335 |
Rwork | 0.181 |
R-free | 0.22285 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2h14 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.435 |
Data reduction software | iMOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0189) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 59.080 | |
High resolution limit [Å] | 1.680 | |
Rpim | 0.030 | 0.420 |
Number of reflections | 33411 | |
<I/σ(I)> | 15.7 | |
Completeness [%] | 99.8 | |
Redundancy | 7.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 5.9 | 295 | 100 mM Bis-Tris pH5.9, 32% PEG3350, 54.6 mM Ammonium Sulfate, 0.66 mM symmetric dimethyl-L-arginine |